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InfectionEndothelial cell injury/dysfunction is considered to play a critical role in the pathogenesis of severe sepsis
and septic shock. Although it is considered that endothelial cell apoptosis is involved in endothelial injury/
dysfunction, physiological involvement remains ambiguous since the induction of apoptosis requires the
inhibition of endogenous apoptosis inhibitors. Here we show that caspase-3 activation, a biological indicator
of apoptosis, is observed in response to lipopolysaccharide (LPS) stimulation even under the inﬂuence of
endogenous apoptosis inhibitors, and that activated caspase-3 is rapidly released from human umbilical vein
endothelial cells (HUVEC). In the presence of cycloheximide (CHX), an increase in intracellular caspase-3/7
activity in response to LPS was not detected in HUVEC up to 24 h following stimulation even in the presence
of LPS-binding protein (LBP), soluble CD14 and soluble MD-2, whereas the decrease in cell viability and
increase in release of the cellular enzyme lactate dehydrogenase (LDH) were observed in a soluble CD14/
LBP-dependent manner. On the other hand, even in the absence of CHX, a signiﬁcant increase in caspase-3/7
activity and a cleaved caspase-3 fragment with a slight increase in LDH release was observed in culture
supernatants in response to LPS. This increase in caspase-3/7 activity was observed even when LDH release
was undetected. These results indicate that caspase-3 is activated by LPS under physiological conditions and
suggest that HUVEC escape from cell death by rapidly releasing activated caspase-3 into extracellular space.
Failure of this escape mechanism may result in endothelial injury/dysfunction.© 2009 Elsevier B.V. All rights reserved.1. Introduction
Sepsis, the systemic inﬂammatory response to infection, is
manifested by two or more of the criteria that deﬁne systemic
inﬂammatory response syndrome [1]. Severe sepsis is a condition
complicated by organ dysfunction and septic shock (hypotension
despite adequate ﬂuid resuscitation). The end of the spectrum is
multiple organ dysfunction syndrome, which is deﬁned as the
presence of altered organ function in an acutely ill patient and
homeostasis that cannot be maintained without intervention [2].
Although infectious diseases can be successfully treated with
medications and other therapeutic measures such as intensive care,an umbilical vein endothelial
H, lactate dehydrogenase; TLR,




ll rights reserved.sepsis is a leading cause of mortality among severely ill patients.
Angus et al. estimate that 750,000 cases of severe sepsis occur each
year in the United States, with a mortality rate of 28.6% [3]. Other
studies suggest that 28-day mortality rates of severe sepsis may be
50% or greater [4].
Lipopolysaccharide (LPS), a constituent of the outer membrane of
the cell wall of Gram-negative bacteria, is the primary factor in the
development of sepsis [5–6]. LPS-induced cell activation depends on
the presence of at least four proteins; Toll-like receptor (TLR) 4, MD-2,
CD14 and LPS-binding protein (LBP) [7–8]. LPS initially binds to LBP in
the blood and is transferred to CD14, a 55-kDa glycoprotein [9]. The
CD14/LPS complex then interacts with the TLR4/MD-2 complex,
leading to cell activation. MD-2 is produced by several cells as a 20- to
25-kDa glycoprotein and binds to LPS to confer LPS responsiveness to
TLR4-expressing cells [10].
Endothelial injury/dysfunction is also critical in sepsis pathogen-
esis [11]. The vascular endothelium is a pervasive organ; the human
body contains approximately 1013 endothelial cells, covering a surface
area of 4000 m2 to 7000 m2 and weighing 1 kg [12]. It serves a
multitude of functions that help to maintain organ homeostasis,
1012 T. Shioiri et al. / Biochimica et Biophysica Acta 1792 (2009) 1011–1018including vasoregulation and selective vascular permeability, and
provision of an anticoagulant surface [13]. In sepsis, the endothelium
undergoes functional and mechanical changes that contribute to
pathogenesis. Apoptosis is a form of cell death that is morphologically
characterized by chromatin condensation, nuclear fragmentation, cell
shrinkage, and blebbing of the plasma membrane. The end result of
apoptosis is fragmentation of the cell into small membrane-bound
bodies. These changes are accomplished by a specialized family of
cysteine-dependent aspartate-directed proteases, termed caspases;
hence apoptosis is biochemically characterized by the activation of
caspases [14]. The caspase gene family consists of 15 mammalian
members classiﬁed based on the structure and function of their
prodomains [15]. The caspase family can be divided into two
functional subgroups based on their roles. Inﬂammatory caspases
(caspase-1, -4, -5, 11, -12, -13 and -14) play a role in cytokine
maturation and inﬂammatory responses. The caspases involved in
apoptosis are further divided into two functional subgroups, initiator
of apoptosis caspases (caspase-2, -8, -9, -10 and -15) and effector
caspases (caspase-3, 6, 7) [16–17].
Endothelial apoptosis is considered to be involved in septic
endothelial injury/dysfunction [18]. However, whether apoptosis is
induced in a physiological condition remains ambiguous since in most
studies [19–20] LPS does not induce apoptosis unless the synthesis of
endogenous apoptosis inhibitors [21–23], such as FLICE-like inhibitory
protein [24], is blocked by protein synthesis inhibitors. Here, we
investigated LPS-induced endothelial cell apoptosis by systematically
examining the activity of effecter caspases (caspase-3/7), cellular
viability as well as LDH release, which reﬂects cellular cytotoxicity. We
found that caspase-3 is activated by LPS in HUVEC even in a
physiological condition and that activated caspase-3 is rapidly
released from cells.
2. Materials and methods
2.1. Cell culture and reagents
RAW 264, a mouse macrophage-like cell line (obtained from the
Riken Cell Bank, Tsukuba, Japan), was maintained in Dulbecco's
modiﬁed Eagle's medium (Invitrogen, Carlsbad, CA), supplemented
with 10% (v/v) heat-inactivated fetal bovine serum (FBS; Invitro-
gen), penicillin (100 U/ml), and streptomycin (100 μg/ml) as
described earlier [25]. Human umbilical vein endothelial cells
(HUVEC) were purchased from Kurabo (Tokyo, Japan) and main-
tained in human endothelial-serum free medium (HE-SFM; Gibco-
BRL, Rockville, MD) supplemented with 0.5% (v/v) heat-inactivated
FBS, recombinant human epidermal growth factor (10 μg/ml;
Invitrogen), recombinant human basic ﬁbroblast growth factor
(20 μg/ml; Wako Pure Chemical Industries, Osaka, Japan), ampho-
tericin B (250 μg/ml; Wako Pure Chemical Industries) and
gentamicin (50 μg/ml; Gibco-BRL) at 37 °C in 5% CO2. HUVEC
were used from passage 4 to 8. LPS from Escherichia coli O111:B4
and cycloheximide (CHX) were purchased from Sigma-Aldrich (St.
Louis, MO). Soluble CD14 (sCD14) was obtained from R&D Systems
(Minneapolis, MN). LBP and soluble MD-2 (sMD-2) were prepared
as described [26]. Anti-caspase-3 (No. 9662) and anti-caspase-7Fig. 1. Effect of LPS on cell viability and intracellular caspase-3/7 activity in HUVEC and RAW
containing 100 ng/ml LBP with (left) or without (right) 20 μg/ml CHX in the presence or ab
and viability (B) were measured. The measured caspase-3/7 activities were corrected with t
caspase-3/7 activity values obtainedwithout LPS in the absence of CHXwere deﬁned as 100%
CHX (0.2–20 μg/ml). Intracellular caspase-3/7 activity was measured after a 7-hour incubati
are the means±S.E.M. from at least four independent experiments. ⁎P b0.05: compared wi
statistically signiﬁcant increasewas observed at the following points: A (−CHX): LPS 1, 10, 10
A (+CHX): LPS 1000 ng/ml in the absence of sCD14 and sMD-2; B (+CHX): LPS 0.1, 1000 ng/
(−CHX): LPS 1, 10 ng/ml in the presence of sCD14; LPS 1, 10, 1000 ng/ml in the presence
following points: A (+CHX): LPS 100, 1000 ng/ml in the presence of sCD14 and sCD14 and s(No. 9492) polyclonal antibodies were purchased from Cell Signal-
ing Technologies (Danvers, MA), and anti-caspase-7 polyclonal
antibody N-17 and anti-LDH polyclonal antibody H-160 were
obtained from Santa Cruz Biotechnology (Santa Cruz, CA).
2.2. Cell stimulation
RAW 264 cells were seeded in 6-well cell culture plates. The
following day, the cells were washed twice with 200 μl of cold
phosphate-buffered saline (PBS) and stimulated in the culture
medium with the indicated concentrations of LPS with or without
0.2–20 μg/ml of CHX. HUVEC were seeded into 96-well cell culture
plates. After a 16-hour incubation, the cells were washed twice with
200 μl of cold PBS and stimulated with the indicated concentrations
of LPS in HE-SFM containing LBP (100 ng/ml) in the presence
or absence of 20 μg/ml of CHX, sCD14 (1 μg/ml) and/or sMD-2
(1 μg/ml).
2.3. Cell viability assay
Cell viability was determined using the CellTiter 96 AQueous One
Solution Cell Proliferation Assay Kit (Promega). HUVEC culture
medium was collected following stimulation and subjected to
cytotoxicity and caspase-3/7 assays as described below. Cells were
washed twice with 200 μl of cold PBS and incubated in a 20%
solution of [3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphe-
nyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt; MTS] in FBS-free
HE-SFM for 1 h at 37 °C in 5% CO2. The amount of formazan
converted by viable cells was determined by measuring absorbance
at 490 nm after subtracting the absorbance at 650 nm on a 96-well
microplate reader.
2.4. LDH release
LDH release was assessed by determining LDH activity in culture
supernatants using the CytoTox 96 Cytotoxicity Assay System
(Promega). Culture supernatants were collected after stimulation
and centrifuged at 4000 rpm for 5 min. The supernatants were
incubated with the assay buffer and substrate mix at room
temperature for 30 min and the absorbance at 490 nmwas measured
using a 96-well microplate reader. The background (spontaneous LDH
release) value was measured in non-stimulated cells and subtracted
from each measurement. Maximum LDH release was measured by
incubating non-stimulated cells in a lysis solution (1% Triton X-100,
PBS) at 37 °C for 1 h.
2.5. Caspase-3/7 activity assay
The caspase-3/7 activity in cell extracts and culture supernatants
was determined using Caspase-Glo 3/7 Assay (Promega). After
stimulation, RAW 264 cells were washed twice with cold PBS and
lysed with 100 μl of lysis buffer [10 mM HEPES–KOH, pH 7.9, 10 mM
KCl, 5 mM EDTA, 40 mM β-glycerophosphate, 0.5% Nondiet P-40
(NP-40), 30 mM NaF, 1 mM Na3VO4] containing a protease inhibitor
cocktail (Roche Diagnostics, Mannheim, Germany). The lysates were264 cells. HUVEC were stimulated with the indicated concentrations of LPS in HE-SFM
sence of 1 μg/ml sCD14 and/or sMD-2. After 24 h , intracellular caspase-3/7 activity (A)
he corresponding viabilities (C). Measured caspase-3/7 activity, viability and corrected
. D: RAW264 cells were treatedwith the indicated concentrations of LPS with or without
on. The activity obtained without LPS in the absence of CHX was deﬁned as 100%. Values
th the respective value without LPS by a two-tailed Student's paired t-test. Note that a
0 ng/ml in the presence of sCD14; LPS 1, 10 ng/ml in the presence of sCD14 plus sMD-2;
ml in the absence of sCD14 and sMD-2; LPS 1, 10, 100 ng/ml in the presence of sMD-2; C
of sCD14 plus sMD-2 and that a statistically signiﬁcant decrease was observed at the
MD-2; B (+CHX): LPS 100, 1000 ng/ml in the presence of sCD14 and sCD14 and sMD-2.
1013T. Shioiri et al. / Biochimica et Biophysica Acta 1792 (2009) 1011–1018centrifuged at 4000 rpm for 5 min and caspase-3/7 activity was
measured in the resulting supernatants. HUVEC were washed twice
following stimulation with cold PBS and directly lysed with 50 μl of
caspase-3/7 detection reagent. Culture supernatants collected afterstimulation were centrifuged at 4000 rpm for 5 min. An equal
volume of caspase-3/7 detection reagent was added to RAW 264
cell extracts and culture supernatants, and the mixture as well as
the HUVEC lysates prepared above were incubated at 25 °C for
Fig. 2. Decrease in viability in response to LPS is caspase-dependent. HUVEC were
stimulated without or with 100 ng/ml of LPS in HE-SFM containing 100 ng/ml LBP,
1 μg/ml sCD14 and 20 μg/ml CHX in the presence or absence of increasing
concentrations of z-VAD-FMK. After 24 h , cellular viability was measured. Values are
the means±S.E.M. from four independent experiments Viability obtained without LPS
in the absence of z-VAD-FMK was deﬁned as 100%.
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with a luminometer.
2.6. Electrophoresis and Western blotting
HUVEC were seeded in 6-well collagen-coated cell culture plates
and stimulated as indicated. Following stimulation, culture super-
natants were collected and centrifuged at 4000 rpm for 5 min. SDS
(ﬁnal concentration: 0.25%), DTT (ﬁnal concentration: 1 mM) and a
protease inhibitor cocktail (Nacalai Tesque, Kyoto, Japan) were
added to the supernatants and the mixture was boiled for 5 min.
The boiled mixture was cooled to room temperature and passed
through AmiconUltra-4 Centrifugal Filter Devices (MW cutoff:
50,000). Proteins in the ﬁltrate were concentrated using trichlor-
oacetic acid precipitation. The precipitate was dissolved in 20 μl of
SDS-sample buffer and subjected to 15% SDS-PAGE followed by
Western blot analysis as previously described [27].
2.7. Statistical analysis
All data are presented as means±SEM. Statistical analyses were
performed using the two-tailed Student's paired t-test. Differences
were judged statistically signiﬁcant when P b0.05.Fig. 3. Time course proﬁle of intracellular caspase-3/7 activity in response to LPS in HUVEC. H
ml LBP and 1 μg/ml sCD14, in the absence (left) and presence (right) of 20 μg/ml CHX. Ca
caspase-3/7 activities were corrected using the corresponding viabilities and %caspase-3/7
LPS in the absence of CHX at time 0 h as 100%. Values are the means±S.E.M. from three inde
tailed Student's paired t-test.3. Results
3.1. Intracellular caspase-3/7 activities of HUVEC and RAW 264 cells
We ﬁrst examined the intracellular caspase-3/7 activity in
response to LPS stimulation. HUVEC were stimulated with the
indicated concentrations of LPS in culture medium containing
100 ng/ml LBP with or without 1 μg/ml sCD14 and/or sMD-2.
After cell viability was measured, the cells were washed and cellular
caspase-3/7 activity was determined. Although statistical signiﬁ-
cance was sporadically observed in some points, no dose-dependent
effects in response to LPS were observed for either caspase-3/7
activity (Fig. 1A left) or the viability (Fig. 1B left) irrespective of the
presence/absence of sCD14 and/or sMD-2. Since changes in viability
affect total caspase-3/7 activity, measured caspase-3/7 activities
were normalized by viability (Fig. 1C left). However, no signiﬁcant
effects were observed in the normalized caspase-3/7 activities.
We next examined the effect of LPS in the presence of CHX
since endogenous apoptosis inhibitors may prevent apoptosis in
HUVEC. Cells were stimulated as described above in the presence of
20 μg/ml CHX, and viability and cellular caspase-3/7 activity were
measured. No dose-dependent effects in response to LPS were
observed in caspase-3/7 activity (Fig. 1A right) or viability (Fig. 1B
right) regardless of the presence/absence of sMD-2. On the other
hand, both were decreased in response to LPS when sCD14 was
present. Normalization of caspase-3/7 activity by viability again
produced no signiﬁcant effect in the response to LPS (Fig. 1C right).
Cellular caspase-3/7 activity was also measured in RAW 264, a
macrophage-like cell line used as a positive control (Fig. 1D). Activity
was determined after cells were stimulated with the indicated
concentrations of LPS. Very little activation of caspase-3/7 was
observed with the addition of 0.2 μg/ml CHX. However, stimulation
with LPS signiﬁcantly increased caspase-3/7 activity in the presence
of 2 and 20 μg/ml CHX.
We next asked whether the decrease in viability observed in
response to LPS in the presence of CHX and sCD14 was caspase-
dependent or not. After HUVEC were stimulated without or with
100 ng/ml LPS for 24 h in culture medium containing 100 ng/ml LBP,
1 μg/ml sCD14 and 20 μg/ml CHX in the presence or absence of
increasing concentrations of a broad spectrum caspase inhibitor z-
VAD-FMK, cell viability was measured. LPS stimulation signiﬁcantly
decreased the viability and the decrease was inhibited by z-VAD-FMK
in a concentration-dependent manner (Fig. 2). z-VAD-FMK at 50 μMUVEC were stimulated without or with 100 ng/ml of LPS in HE-SFM containing 100 ng/
spase-3/7 activity and viability were measured at the indicated time points. Measured
activity was expressed by deﬁning the corrected caspase-3/7 activity obtained without
pendent experiments. ⁎P b0.05: compared with activity in the absence of LPS by a two-
Fig. 4. LDH and caspase-3/7 activities in culture supernatants of HUVEC in response to LPS. HUVEC were stimulated with the indicated concentrations of LPS in HE-SFM containing
100 ng/ml LBP without (left) or with (right) 20 μg/ml CHX in the presence or absence of 1 μg/ml sCD14 and/or sMD-2. After 24 h , LDH level (upper) and caspase-3/7 activity in the
culture supernatant (lower) were measured. Values are the means±S.E.M. from at least three independent experiments. Each value for LDH activity obtained without LPS in the
presence and absence of CHX were deﬁned as 0%. Caspase-3/7 activity obtained without LPS in the absence of CHX was deﬁned as 100%. ⁎P b0.05: compared with the respective
response in the absence of LPS by a two-tailed Student's paired t-test.
Fig. 5. LDH proteins and cleaved caspase-3 were detected in HUVEC culture
supernatants. HUVEC were stimulated without or with 100 ng/ml of LPS in HE-SFM
containing 100 ng/ml LBP and 1 μg/ml sCD14 in the presence and absence of 20 μg/ml
CHX. After 24 h, an equal volume of culture supernatants was collected and
concentrated as described in the Materials and methods and caspase-3 (upper) and
LDH (lower) were detected byWestern blotting. A representative of three independent
experiments with similar results is shown.
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decrease in viability was caspase-dependent.
Since intracellular caspase-3/7 activity was not detected in HUVEC
in response to LPS, caspase-3/7 activity was measured during a time
course following LPS stimulation (Fig. 3). HUVEC were stimulated
with 100 ng/ml LPS in culture medium containing 100 ng/ml LBP and
1 μg/ml sCD14 in the presence or absence of CHX (20 μg/ml). In the
absence of CHX (left), no signiﬁcant changes in intracellular caspase-
3/7 activity were observed throughout the incubation period, and LPS
stimulation did not increase activity. In the presence of CHX (right), a
time-dependent increase in intracellular caspase-3/7 activity was
observed. However, LPS stimulation did not further increase this
activity.
3.2. Caspase-3/7 and LDH activities were detected in HUVEC culture
supernatants after LPS stimulation
After HUVEC were stimulated without or with LPS for 24 h in
culture medium containing 100 ng/ml LBP and 1 μg/ml sCD14 in the
presence or absence of CHX (20 μg/ml), culture supernatants were
collected for the measurements of caspase-3/7 activity and LDH
release (Fig. 4). Unexpectedly, we found that caspase-3/7 activity in
the culture supernatants was signiﬁcantly increased in response to
LPS stimulation both in the absence (left-bottom) and presence
(right-bottom) of CHX in a sCD14-dependent manner. Caspase-3/7
activity without LPS stimulation was lower than when CHX was
present. However, a signiﬁcant increase in caspase-3/7 activity was
observed in response to LPS in the presence of sCD14. Consistent with
the decrease in viability (Fig. 1), LDH release from HUVEC was
increased in response to LPS in the presence of CHX in a sCD14-
dependent manner (Fig. 4 right-upper). The LDH release was parallel
with caspase-3/7 activity in the culture supernatants (Fig. 4 right-
lower). On the other hand, only a small increase in LDH release wasobserved in the absence of CHX at higher concentrations of LPS in the
presence of sCD14 (Fig. 4 left-upper).
To exclude the possibility that proteases other than caspase-3/7
were responsible for the cleavage of the caspase-3/7-speciﬁc
substrate used to assess activity, we measured caspase-3/7 activity
after adding a speciﬁc caspase-3/7 inhibitor (Z-DEVD-FMK) to culture
supernatants after collection. Caspase-3/7 activity was completely
inhibited by 5 μM of inhibitor (data not shown), indicating that
measured activity was derived from caspase-3/7.
We also used Western blot analysis to measure caspase-3/7
proteins in culture supernatants (Fig. 5 upper panel). Caspase-3 was
hardly detectable in the culture supernatant of non-stimulated cells
but cleaved caspase-3 (p17 fragment) was clearly observed in
culture supernatant from LPS-stimulated cells. The addition of CHX
also increased the level of cleaved caspase-3, which was further
enhanced by LPS stimulation in the presence of CHX. A protein band
1016 T. Shioiri et al. / Biochimica et Biophysica Acta 1792 (2009) 1011–1018was detected at the molecular weight size close to full-length
caspase-3, however the appearance was not reproducible (data not
shown).
Cytotoxicity was also evaluated during incubation periods via
examination of LDH protein released into culture supernatants (Fig. 5
lower panel). The trace amount of LDH detected in the culture
supernatant of non-stimulated cells was slightly increased by LPS
stimulation. The addition of CHX increased the LDH level, which was
further augmented by LPS stimulation in the presence of CHX. Two
different anti-caspase-7 antibodies that detected procaspase-7 in
HUVEC cellular extracts did not detect caspase-7 in the culture
supernatants (data not shown).
3.3. Caspase-3/7 activity detected in culture supernatants without
accompanying LDH release
Since the increase in cleaved caspase-3 fragment in culture
supernatants was much greater than the increase in LDH release in
the absence of CHX (Fig. 5), we examined caspase-3/7 and LDH
activities in culture supernatants at various time points following
LPS stimulation (Fig. 6). HUVEC were stimulated without or with
100 ng/ml LPS for the indicated time in culture medium containing
100 ng/ml LBP and 1 μg/ml sCD14 in the presence (right) or
absence (left) of CHX (20 μg/ml), and the supernatants were
collected for the measurements of caspase-3/7 activity and LDH
release. Caspase-3/7 activity gradually increased with time and LPS
stimulation signiﬁcantly enhanced the activities both in the absence
(left-upper) and presence (right-upper) of CHX. A statisticallyFig. 6. Time course proﬁle of caspase-3/7 and LDH activities in HUVEC culture supernatants i
containing 100 ng/ml LBP and 1 μg/ml sCD14, in the absence (left) and presence (right) of
were measured at the indicated time points. Net caspase-3/7 activities are shown. In LDH rel
deﬁned as 0%. Values are the means±S.E.M. from three independent experiments. ⁎P b0.05
tailed Student's paired t-test.signiﬁcant enhancement was observed after 12 h and 8 h following
LPS stimulation in the absence and presence of CHX, respectively.
No LDH release was observed in the absence of CHX (left-lower)
regardless of the presence or absence of LPS stimulation. In the
presence of CHX (right-lower), LDH release gradually increased over
time and tended to be enhanced by LPS.
4. Discussion
Although LPS-induced endothelial cell apoptosis has been
reported in some studies, discrepancies exist regarding the
inducibility of apoptosis and the requirement of protein synthesis
inhibitors for the induction of apoptosis. The endothelial cell lines
and/or methods used to evaluate apoptosis may inﬂuence these
differences. Although it has been shown that LPS directly induces
cell death in a bovine endothelial cell line [28–29], most studies
using human endothelial cells showed that these cells require
protein synthesis inhibitors such as CHX for the induction of
apoptosis in response to LPS [24,30]. Various methods were
employed to measure endothelial injury in these studies. For
example, Hu et al. examined cell viability by MTT assay [30] and
Bannerman et al. examined caspase activities [24]. In the present
study, we systematically evaluated endothelial injury with the MTS
viability assay, LDH release (cytotoxicity) and caspase-3/7 activity
both intracellularly and in culture supernatants in the presence and
absence of a protein synthesis inhibitor, CHX. As reported
previously, we also observed in this study that LPS induces a
decrease in viability (Fig. 1) and an increase in cytotoxicity (Fig. 4)n response to LPS. HUVEC were stimulated with or without 100 ng/ml of LPS in HE-SFM
20 μg/ml CHX. Caspase-3/7 (upper) and LDH (lower) activities in culture supernatants
eases, each LDH activity value obtained at time 0 in the presence or absence of CHX was
: compared with activity in the absence of LPS at the respective time points by a two-
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3/7 were not affected by LPS stimulation in the absence of CHX (Fig.
1) although a small increase in cytotoxicity was observed (Fig. 4).
However, surprisingly, we found that LPS induced a signiﬁcant
increase in caspase-3/7 activity (Figs. 4 and 6) in culture super-
natants even in the absence of CHX. This activity was completely
inhibited by a speciﬁc caspase-3/7 inhibitor (data not shown) and
the cleaved p17 caspase-3 fragment was detected in the supernatant
(Fig. 5), indicating that at least active caspase-3 was released into
the supernatant. Because only intracellular caspase-3/7 activities
were examined in most studies, activation of caspase-3 in the
absence of CHX might not have been detected.
It is likely that cleaved active caspase-3 is rapidly released from
cells in the absence of CHX because the activation of intracellular
caspase-3/7 in response to LPS was not observed at any of the time
points examined (Fig. 3). In the presence of CHX, it is plausible that
most of the cleaved caspase-3 was derived from cells that lost
membrane integrity because a considerable decrease in viability
(Fig. 1) and increase in LDH release (Figs. 4–6) were observed.
However, cleaved caspase-3 was also detectable (Fig. 5) in response
to LPS in the absence of CHX although no signiﬁcant changes in
viability were observed (Fig. 1). Apparently viability may remain
unchanged if LPS increases cell growth or cellular NADH activity,
which is used to evaluate viability in this study. Thus, we measured
the release of LDH into culture supernatants and found that it was
only slightly increased by higher concentrations of LPS in the
absence of CHX at 24 h following stimulation (Fig. 4). LDH protein
in culture supernatants, examined in parallel with the detection of
cleaved caspase-3, was also slightly increased in response to LPS
(Fig. 5). Therefore, at least some parts of cleaved caspase-3 may be
derived from cells that have lost membrane integrity. It is currently
unknown if this loss of membrane integrity is caused by the
activation of caspase-3. LPS may induce the production of
substances that cause necrotic cell death in HUVEC. However, the
LPS-induced increase in cleaved caspase-3 protein is obviously
greater than the increase in LDH protein in culture supernatants
(Fig. 5). Furthermore, the LPS-induced increase in caspase-3/7
activity in culture supernatants occurred without an increase in LDH
release at earlier time points (Fig. 6). Therefore, it is probable that a
certain amount of cleaved caspase-3 was derived from cells that had
not lost membrane integrity. It is widely known that interleukin-1β
and caspase-1, which lack a signal peptide sequence for secretion,
are secreted from cells via an unconventional endoplasmic reticu-
lum/Golgi-independent pathway [31–32]. Other proteins that have
no signal peptides but are secreted have also been identiﬁed [32].
Further study may reveal an as yet unknown secretion mechanism
for cleaved caspase-3.
In HUVEC, the decrease in viability, increase in LDH release and
activation of caspase-3/7 in response to LPS were dependent on
the presence of sCD14 and LBP but were independent of the
presence of sMD-2 (Figs. 1 and 4). It is reported that endothelial
cells lack membrane CD14 and only TLR4 and MD-2 are expressed
[33–34]. We also conﬁrmed by real time RT-PCR that HUVEC
expressed TLR4 and MD-2 mRNAs but have limited expression of
CD14 mRNA (data not shown). Since it has been reported that
serum sCD14 levels are increased in septic patients [35], the
reduction of sCD14 level may suppress the induction of endothelial
cell apoptosis and contribute to improvement of endothelial cell
injury/dysfunction.
Since most studies have reported that LPS-induced apoptosis
develops only in the presence of protein synthesis inhibitors, such
as CHX, it has been pointed out that the results do not always
reﬂect physiological reactions and it has been unclear whether
apoptosis is involved in endothelial injury/dysfunction that occurs
under sepsis. Although there is evidence to suggest that the
survival pathway may fail due to inhibition by other inﬂammatorymediators or cytokines during sepsis [36–37], our results clearly
demonstrate that LPS activates caspase-3 even in the absence of
CHX and that activated caspase-3 is rapidly released from cells
without causing cell death. It is likely that HUVEC escape from cell
death by releasing activated caspase-3 induced by LPS stimulation.
In the presence of CHX, this protection mechanism appears to fail
because active caspase-3 accumulated in HUVEC (Fig. 3) and
caspase-dependent cell death occurred (Figs. 2 and 5). Studying
this mechanism will clarify the role of LPS-induced apoptosis in the
pathogenesis of endothelial injury/dysfunction under sepsis.Acknowledgments
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